ALPS Advisors’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$729K Sell
35,812
-14,126
-28% -$287K ﹤0.01% 579
2025
Q1
$906K Sell
49,938
-3,712
-7% -$67.4K 0.01% 485
2024
Q4
$1.36M Buy
53,650
+2,993
+6% +$75.6K 0.01% 410
2024
Q3
$1.72M Sell
50,657
-742
-1% -$25.2K 0.01% 383
2024
Q2
$1.9M Buy
51,399
+5,959
+13% +$221K 0.01% 346
2024
Q1
$1.91M Buy
45,440
+7,795
+21% +$327K 0.01% 359
2023
Q4
$1.49M Buy
37,645
+2,797
+8% +$111K 0.01% 383
2023
Q3
$959K Buy
34,848
+113
+0.3% +$3.11K 0.01% 465
2023
Q2
$1.18M Buy
34,735
+3,630
+12% +$123K 0.01% 437
2023
Q1
$1.12M Sell
31,105
-844
-3% -$30.4K 0.01% 446
2022
Q4
$1.42M Buy
31,949
+6,389
+25% +$285K 0.01% 368
2022
Q3
$718K Sell
25,560
-2,180
-8% -$61.2K 0.01% 536
2022
Q2
$748K Buy
+27,740
New +$748K 0.01% 517
2021
Q2
Sell
-71,581
Closed -$1.48M 906
2021
Q1
$1.48M Buy
71,581
+861
+1% +$17.7K 0.01% 353
2020
Q4
$1.24M Buy
+70,720
New +$1.24M 0.01% 366
2017
Q2
Sell
-7,013
Closed -$380K 773
2017
Q1
$380K Buy
7,013
+526
+8% +$28.5K ﹤0.01% 671
2016
Q4
$344K Sell
6,487
-2,058
-24% -$109K ﹤0.01% 655
2016
Q3
$518K Sell
8,545
-700
-8% -$42.4K ﹤0.01% 265
2016
Q2
$609K Buy
9,245
+1,845
+25% +$122K 0.01% 229
2016
Q1
$420K Sell
7,400
-1,263
-15% -$71.7K ﹤0.01% 531
2015
Q4
$2.04M Sell
8,663
-1,613
-16% -$379K 0.02% 177
2015
Q3
$16.2K Buy
10,276
+3,761
+58% +$5.95K 0.02% 183
2015
Q2
$2.47M Buy
6,515
+3,305
+103% +$1.25M 0.02% 152
2015
Q1
$1.34M Buy
+3,210
New +$1.34M 0.01% 170